Unity’s Runtime Fee is officially dead in the water. Exactly one year after its infamous announcement, new CEO Matt Bromberg has made his stamp on the firm - to end the madness and, to coin a sporting ...
Unity Biotechnology and Mammoth Biosciences are both turning toward cost-saving measures, prompting layoffs at both companies. Unity’s restructuring comes along with 36-week results from its phase 2b ...
Unity reported strong earnings on Wednesday and the stock is flying. Q1 results support the operating leverage we thought was coming from ironSource. The chart supports higher prices and margins ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback